Uses of Solu Medrol

Solu Medrol is used by doctors to treat symptoms such as: anaphylaxis emergency, osteoarthritis treatment, terminal cancer, pneumonia... To find out what Solu Medrol is, you have You can refer to the article below.

Solu - Medrol 40mg is indicated for use in the following cases:
Adjuvant treatment for life-threatening cases. Treatment of the following disorders due to failure to respond to standard therapy (or during exacerbations): Rheumatic disorders, systemic lupus erythematosus, multiple sclerosis, edematous states such as glomerulonephritis due to lupus. Treatment of terminal cancer (to improve quality of life). Preventing nausea and vomiting caused by cancer chemotherapy. Treatment of acute spinal cord injury. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Treatment of exacerbations of chronic obstructive pulmonary disease (COPD). Supportive treatment for other indications.

2.1. Administration of Solu Medrol Solu-Medrol can be administered intravenously, intramuscularly or intravenously, the preferred method for primary care is intravenous injection. For intravenous (or intramuscular) administration, prepare the solution according to the required dose instructions, which can be administered intravenously over a period of several minutes. If necessary, the drug can be diluted with additional water, for injection or other suitable solvent into Act-O-Vial and withdrawn the indicated dose.
To prepare IV solution, first prepare solution for injection as directed. This solution may then be injected with the necessary amount of 5% dextrose in water, isotonic saline or 5% dextrose in isotonic saline.
Instructions for using the Act-O-Vial kit:
Press down on the plastic button to push the solvent into the lower compartment. Shake gently to make solution. Remove the plastic covering the stopper center. Disinfect the stopper tip with an appropriate disinfectant. Hold the needle perpendicularly through the center of the stopper until the point of the needle is visible. Turn the bottle over and withdraw the medicine. 2.2. Dosage of the drug Solu Medrol When treatment with high doses is required, intravenous infusion of sterile powder Solu-Medrol. 30 mg/kg for at least 30 minutes. This dose may be repeated every 4-6 hours for 48 hours.
In general, only continue high doses until the patient's condition has stabilized, usually no more than 48-72 hours.
Although side effects from short-term high-dose corticosteroid therapy are uncommon, peptic ulcers can occur. Prophylaxis with antacids may be indicated.
In other indications the dose varies from 10-40mg methylprednisolone depending on the clinical situation. Higher doses may be needed for a short time to control an acute, severe condition. The therapeutic dose should be administered intravenously over several minutes. Subsequent doses may be given intravenously or intramuscularly at intervals depending on the patient's response and clinical condition. Corticosteroids are used as adjunctive therapy and are not a substitute for conventional therapy.
Dosage for young children and older children can be reduced but should be based on the severity of the disease and not on age and body weight. Doses of less than 0.5 mg per kg body weight should be administered every 24 hours.
Dosage must be gradually reduced or discontinued after several days of use. If a period of spontaneous remission occurs in the chronic case, the drug should be discontinued.
Routine tests such as urinalysis, 2 h postprandial blood glucose, blood pressure and weight measurements, and chest x-ray should be done at regular intervals throughout the long course of treatment. Radiographs of the upper gastrointestinal tract are required in patients with a history of ulcers or gastrointestinal disorders.

Solu - Medrol 40mg is contraindicated in the following cases:
Systemic fungal infections. Hypersensitivity to methylprednisolone or any of the excipients. The use of live or live attenuated vaccines is contraindicated in patients receiving immunosuppressive doses of corticosteroids.

Before taking Solu Medrol, you should tell your doctor or pharmacist if:
You are pregnant or breast-feeding. You need to take the medicine prescribed by your doctor in this case Allergy to any ingredient of Solu Medrol should not use the medicine You are taking other medicines (including prescription, nonprescription, herbal Medicines and supplements) You are planning to give the medicine to a child or the elderly You have recently had a vaccination, because this medicine is not used together with some vaccines. Liver, kidney disease, hypothyroidism, myasthenia gravis/colon/diverticulum, heart disease, tuberculosis, myasthenia gravis, adrenal or pituitary gland disease, diabetes or elevated blood sugar. Emotional and mental disorders, recent head trauma Herpes virus infection in the eye Any pus-producing infections Edema or convulsions Blood clots Do not start treatment with Solu Medrol if you have a severe fungal infection, except when specific anti-infective therapy is available and there is cerebral edema in malaria. In addition, absolutely do not use Solu Medrol in immunosuppressive doses with live or attenuated vaccines.
Do not use Solu Medrol directly into the spinal cord or injected locally because of the high risk of side effects. Before doing any test, tell your doctor because the medicine can mask signs of infection or raise blood sugar..., causing false results. The drug may cause dizziness, lightheadedness, visual disturbances and fatigue in some patients, use caution when driving, taking stairs or operating machinery.

Solu Medrol can cause short-term or long-term side effects.
Side effects occurring during or immediately after infusion: changes in blood pressure, arrhythmia, electrolyte imbalance, hyperglycemia, sweating, flushing of the skin, metallic taste in the mouth, difficulty sleep, abnormal mood and behavior, mental confusion, convulsions, susceptibility to infection or anaphylaxis.
Long-term side effects of Solu Medrol include: weight gain, acne breakouts, thinning skin, stretch marks, increased cholesterol, hyperglycemia, peptic ulcer, glaucoma, cataracts, density decreased bone mass, increased risk of osteonecrosis, myasthenia gravis, susceptibility to infection, and growth inhibition.
Long-term treatment with methypresnisolone may affect the growth and development of young children, with the risk of causing increased cranial pressure. Therefore, the use of the drug should be closely monitored.
For elderly people over 65 years old, the risk of weak bones, fractures, water retention causing high blood pressure is higher than young people.
This is not a complete list of side effects and others may occur. If you have any questions about side effects, consult your doctor or pharmacist.